Alpha DNA Investment Management’s Eli Lilly LLY Stock Holding History

Alpha DNA Investment Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-322	Closed	-$285K	–	229
2024 Q3	$285K	Buy	+322	New	+$289K	0.11%	188
2023 Q4	–	Sell	-5,577	Closed	-$3M	–	212
2023 Q3	$3M	Sell	5,577 -568	-9%	-$293K	1.23%	9
2023 Q2	$2.88M	Sell	6,145 -230	-4%	-$96.5K	0.96%	10
2023 Q1	$2.19M	Buy	6,375 +1,648	+35%	+$556K	0.65%	13
2022 Q4	$1.73M	Buy	4,727 +1,103	+30%	+$391K	0.61%	22
2022 Q3	$1.17M	Buy	+3,624	New	+$1.15M	0.97%	27
2021 Q2	–	Sell	-6	Closed	-$1K	–	396
2021 Q1	$1K	Hold	6	–	–	﹤0.01%	630
2020 Q4	$1K	Buy	+6	New	+$896	﹤0.01%	531

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alpha DNA Investment Management's LLY Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 322 shares — an estimated $285K sold.

Alpha DNA Investment Management first reported a position in LLY in Q4 2020 and held it in 8 quarters. The position peaked at $3M in Q3 2023. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

Alpha DNA Investment Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 322 Eli Lilly shares in Q4 2024, an estimated $285K.
Alpha DNA Investment Management first reported a position in Eli Lilly in Q4 2020 and held it in 8 quarters.
Alpha DNA Investment Management's Eli Lilly position peaked at $3M in Q3 2023.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.